FDA approved drugs with antiviral activity against SARS-CoV-2: From structure-based repurposing to host-specific mechanisms

“FDA Approved Drugs With Antiviral Activity Against SARS-CoV-2: From Structure-Based Repurposing to Host-Specific Mechanisms”. 2023. Biomedicine & Pharmacotherapy.

Publisher's Version

Last updated on 08/19/2025

Principal Investigator

Principal Investigator Ngoc Uyen Nhi Nguyen, B.Sc., M.Sc., Ph.D.

Internal Medicine/Cardiology, Morsani College of Medicine, University of South Florida

Center for Regenerative Medicine, University of South Florida Health Heart Institute

See also: Principal Investigator

Current Members

Ching-Cheng Hsu, B.Sc., M.Sc., Ph.D.

See also: Current Members